TILL TRANSAKTIONER
Hälsovård

Väsby Läkargrupp has been acquired by Doktor.se

The shareholders of Väsby Läkargrupp have sold the company to Doktor.se.

Väsby Läkargrupp is a healthcare provider offering primary care, occupational health care and vaccinations through a clinic located in Upplands Väsby in Sweden. The company was founded in 1987 and has approximately 45 employees.

Doktor.se is a digital healthcare and technology company offering digital triage and treatment through its digital healthcare platform as well as through physical clinics in Sweden. The company was founded in 2016 and is one of Sweden’s leading digital healthcare providers.

Oaklins’ team in Sweden acted as financial advisor to the sellers in this transaction.

Prata med transaktionsteamet

Anders Ingler

Senior Advisor
Stockholm, Sverige
Oaklins Sweden

Lars Gustafsson

Partner
Stockholm, Sverige
Oaklins Sweden

Christos Karabelas

Associate
Stockholm, Sverige
Oaklins Sweden

Relaterade transaktioner

Leika Medical Equipments Ltd. has been acquired by Angus Capital
Riskkapital | Hälsovård

Leika Medical Equipments Ltd. has been acquired by Angus Capital

The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.

Lär dig mer
Phen’X Technologies has sold a majority stake to Ciclad
Riskkapital | Hälsovård | Industriella maskiner och komponenter

Phen’X Technologies has sold a majority stake to Ciclad

The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.

Lär dig mer
Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments
Hälsovård | TMT

Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments

Medis Medical Imaging Systems B.V., a leading cardiac imaging software company, have completed a strategic investment to further develop its revolutionary non-invasive cardiovascular imaging solution. The company has announced its collaboration with GE HealthCare (Nasdaq: GEHC), a global leader in medical technology, pharmaceutical diagnostics and innovation in digital solutions, to contribute to the advancement of precision care in the diagnosis and treatment of coronary artery disease (CAD).

Lär dig mer